Evidence map›Paper›PMID 29237686›Full record

Observational studyCirculation. Cardiovascular genetics2017

Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study.

Daniel D Kinnamon, Ana Morales, Deborah J Bowen, Wylie Burke, Ray E Hershberger, DCM Consortium*

Registry-linked trialOpen access · diamondAbstract readObservational Study
In one paragraph

Observational study in Circulation. Cardiovascular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03037632 (Precision Medicine for Dilated Cardiomyopathy in European and African Ancestry), which is not on this map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03037632 naactive not recruitingnot on this map

Precision Medicine for Dilated Cardiomyopathy in European and African Ancestry

TypeinterventionalSponsorRay HershbergerRan2016 to 2026Enrolled6,500ConditionsIdiopathic Dilated CardiomyopathyArmsFamily Heart Talk Booklet
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Effectiveness of theCirculation · 2023
    Trial
  4. Trial
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohort.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2025
    Article
  10. Article
  11. The DCM Project Portal: A direct-to-participant platform of The DCM Research Project.American heart journal plus : cardiology research and practice · 2024
    Article
  12. Article
  13. The DCM Project Portal: A direct-to-participant platform of The DCM Research Project.medRxiv : the preprint server for health sciences · 2023
    Article
  14. Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives.Journal of the American College of Cardiology · 2023
    Article
  15. Review
  16. Review
  17. TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study.Genetics in medicine : official journal of the American College of Medical Genetics · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 20 institutions in 6 countries.

Daniel D KinnamonFrom the Division of Human Genetics (D.D.K., A.M., R.E.H.) and Cardiovascular Division (R.E.H.), Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus; and Department of Bioethics & Humanities, University of Washington, Seattle (D.J.B., W.B.). Daniel.Kinnamon@osumc.edu Ray.Hershberger@osumc.edu.
Ana MoralesFrom the Division of Human Genetics (D.D.K., A.M., R.E.H.) and Cardiovascular Division (R.E.H.), Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus; and Department of Bioethics & Humanities, University of Washington, Seattle (D.J.B., W.B.).
Deborah J BowenFrom the Division of Human Genetics (D.D.K., A.M., R.E.H.) and Cardiovascular Division (R.E.H.), Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus; and Department of Bioethics & Humanities, University of Washington, Seattle (D.J.B., W.B.).
Wylie BurkeFrom the Division of Human Genetics (D.D.K., A.M., R.E.H.) and Cardiovascular Division (R.E.H.), Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus; and Department of Bioethics & Humanities, University of Washington, Seattle (D.J.B., W.B.).
Ray E HershbergerFrom the Division of Human Genetics (D.D.K., A.M., R.E.H.) and Cardiovascular Division (R.E.H.), Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus; and Department of Bioethics & Humanities, University of Washington, Seattle (D.J.B., W.B.). Daniel.Kinnamon@osumc.edu Ray.Hershberger@osumc.edu.
DCM Consortium*
University of Washington · USThe Ohio State University · USCalifornia University of Pennsylvania · USNational Heart Lung and Blood Institute · USStanford University · USTufts Medical Center · USUniversity of Mississippi Medical Center · USBaptist Health South Florida · USCleveland Clinic · USMethodist Hospital · USBarry Callebaut (Belgium) · BEBrentwood Hospital · USEducational Service District 105 · USHarvard University · USID-FISH Technology (United States) · USNational Human Genome Research Institute · USNationwide Children's Hospital · USPenrith Community Hospital · GBPlatt College · USRandall University · US

Funding

Precision Medicine for Dilated Cardiomyopathy in European and African AncestryR01HL128857 · NHLBI · OHIO STATE UNIVERSITY · PI HERSHBERGER, RAY E. · 2015 to 2020
$12.4M
NHLBI NIH HHS R01 HL128857
6 · The paper itself

Abstract

backgroundThe cause of idiopathic dilated cardiomyopathy (DCM) is unknown by definition, but its familial subtype is considered to have a genetic component. We hypothesize that most idiopathic DCM, whether familial or nonfamilial, has a genetic basis, in which case a genetics-driven approach to identifying at-risk family members for clinical screening and early intervention could reduce morbidity and mortality.

methodsOn the basis of this hypothesis, we have launched the National Heart, Lung, and Blood Institute- and National Human Genome Research Institute-funded DCM Precision Medicine Study, which aims to enroll 1300 individuals (600 non-Hispanic African ancestry, 600 non-Hispanic European ancestry, and 100 Hispanic) who meet rigorous clinical criteria for idiopathic DCM along with 2600 of their relatives. Enrolled relatives will undergo clinical cardiovascular screening to identify asymptomatic disease, and all individuals with idiopathic DCM will undergo exome sequencing to identify relevant variants in genes previously implicated in DCM. Results will be returned by genetic counselors 12 to 14 months after enrollment. The data obtained will be used to describe the prevalence of familial DCM among idiopathic DCM cases and the genetic architecture of idiopathic DCM in multiple ethnicity-ancestry groups. We will also conduct a randomized controlled trial to test the effectiveness of

conclusionsWe anticipate that this study will demonstrate that idiopathic DCM has a genetic basis and guide best practices for a genetics-driven approach to early intervention in at-risk relatives. CLINICAL

trial registrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT03037632.

Indexed as

Cardiomyopathy, DilatedGenetic TestingPrecision MedicineBlack or African AmericanCross-Sectional StudiesFemaleHispanic or LatinoHumansMaleOutcome Assessment, Health CarePrevalenceUnited StatesWhite Peoplecommunicationexomegeneticsmorbidityprevalence

Identifiers

PMID29237686
PMCPMC5842914
OpenAlexW2773999756

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.